nodes	percent_of_prediction	percent_of_DWPC	metapath
Anagrelide—Laboratory test abnormal—Entecavir—hepatitis B	0.0356	0.0358	CcSEcCtD
Anagrelide—Influenza-like symptoms—Telbivudine—hepatitis B	0.0171	0.0172	CcSEcCtD
Anagrelide—Bone pain—Adefovir Dipivoxil—hepatitis B	0.0151	0.0152	CcSEcCtD
Anagrelide—Raised liver function tests—Lamivudine—hepatitis B	0.0149	0.015	CcSEcCtD
Anagrelide—Cardiomyopathy—Lamivudine—hepatitis B	0.0134	0.0135	CcSEcCtD
Anagrelide—Neck pain—Telbivudine—hepatitis B	0.0124	0.0124	CcSEcCtD
Anagrelide—Gingival bleeding—Lamivudine—hepatitis B	0.0121	0.0122	CcSEcCtD
Anagrelide—Influenza like illness—Telbivudine—hepatitis B	0.0119	0.0119	CcSEcCtD
Anagrelide—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.0111	0.0111	CcSEcCtD
Anagrelide—Blood creatinine increased—Entecavir—hepatitis B	0.0101	0.0102	CcSEcCtD
Anagrelide—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00986	0.00991	CcSEcCtD
Anagrelide—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.00971	0.00976	CcSEcCtD
Anagrelide—Renal impairment—Telbivudine—hepatitis B	0.00931	0.00936	CcSEcCtD
Anagrelide—Pancreatitis—Entecavir—hepatitis B	0.00914	0.00919	CcSEcCtD
Anagrelide—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00892	0.00896	CcSEcCtD
Anagrelide—Amblyopia—Lamivudine—hepatitis B	0.00891	0.00895	CcSEcCtD
Anagrelide—Migraine—Telbivudine—hepatitis B	0.00872	0.00876	CcSEcCtD
Anagrelide—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00823	0.00827	CcSEcCtD
Anagrelide—Renal failure—Entecavir—hepatitis B	0.00817	0.00821	CcSEcCtD
Anagrelide—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00797	0.00801	CcSEcCtD
Anagrelide—Haematuria—Entecavir—hepatitis B	0.00792	0.00796	CcSEcCtD
Anagrelide—Hepatobiliary disease—Entecavir—hepatitis B	0.00786	0.0079	CcSEcCtD
Anagrelide—Gastritis—Telbivudine—hepatitis B	0.00784	0.00788	CcSEcCtD
Anagrelide—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00773	0.00777	CcSEcCtD
Anagrelide—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00767	0.00771	CcSEcCtD
Anagrelide—Influenza—Telbivudine—hepatitis B	0.00766	0.0077	CcSEcCtD
Anagrelide—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00761	0.00765	CcSEcCtD
Anagrelide—Hepatitis—Entecavir—hepatitis B	0.00746	0.0075	CcSEcCtD
Anagrelide—Oedema peripheral—Entecavir—hepatitis B	0.00735	0.00739	CcSEcCtD
Anagrelide—Abdominal discomfort—Telbivudine—hepatitis B	0.00734	0.00738	CcSEcCtD
Anagrelide—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00728	0.00732	CcSEcCtD
Anagrelide—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00722	0.00726	CcSEcCtD
Anagrelide—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00719	0.00723	CcSEcCtD
Anagrelide—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00715	0.00719	CcSEcCtD
Anagrelide—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00714	0.00717	CcSEcCtD
Anagrelide—Eructation—Lamivudine—hepatitis B	0.00676	0.00679	CcSEcCtD
Anagrelide—Renal failure—Telbivudine—hepatitis B	0.00671	0.00675	CcSEcCtD
Anagrelide—Alopecia—Entecavir—hepatitis B	0.00659	0.00663	CcSEcCtD
Anagrelide—Malnutrition—Entecavir—hepatitis B	0.00649	0.00653	CcSEcCtD
Anagrelide—Hepatobiliary disease—Telbivudine—hepatitis B	0.00646	0.00649	CcSEcCtD
Anagrelide—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00634	0.00637	CcSEcCtD
Anagrelide—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00624	0.00628	CcSEcCtD
Anagrelide—Back pain—Adefovir Dipivoxil—hepatitis B	0.00613	0.00616	CcSEcCtD
Anagrelide—Hepatitis—Telbivudine—hepatitis B	0.00613	0.00616	CcSEcCtD
Anagrelide—Hypoaesthesia—Telbivudine—hepatitis B	0.0061	0.00613	CcSEcCtD
Anagrelide—Pharyngitis—Telbivudine—hepatitis B	0.00608	0.00611	CcSEcCtD
Anagrelide—Connective tissue disorder—Telbivudine—hepatitis B	0.00602	0.00605	CcSEcCtD
Anagrelide—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00586	0.00589	CcSEcCtD
Anagrelide—Lymphadenopathy—Lamivudine—hepatitis B	0.00585	0.00588	CcSEcCtD
Anagrelide—Cough—Adefovir Dipivoxil—hepatitis B	0.00553	0.00556	CcSEcCtD
Anagrelide—Mediastinal disorder—Telbivudine—hepatitis B	0.00552	0.00555	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00549	0.00552	CcSEcCtD
Anagrelide—Injury—Lamivudine—hepatitis B	0.00543	0.00546	CcSEcCtD
Anagrelide—Chest pain—Adefovir Dipivoxil—hepatitis B	0.0054	0.00542	CcSEcCtD
Anagrelide—Myalgia—Adefovir Dipivoxil—hepatitis B	0.0054	0.00542	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00536	0.00539	CcSEcCtD
Anagrelide—Malnutrition—Telbivudine—hepatitis B	0.00534	0.00536	CcSEcCtD
Anagrelide—Infection—Entecavir—hepatitis B	0.00527	0.00529	CcSEcCtD
Anagrelide—Renal impairment—Lamivudine—hepatitis B	0.00525	0.00527	CcSEcCtD
Anagrelide—Nervous system disorder—Entecavir—hepatitis B	0.0052	0.00522	CcSEcCtD
Anagrelide—Back pain—Telbivudine—hepatitis B	0.00516	0.00519	CcSEcCtD
Anagrelide—Skin disorder—Entecavir—hepatitis B	0.00515	0.00517	CcSEcCtD
Anagrelide—Muscle spasms—Telbivudine—hepatitis B	0.00513	0.00516	CcSEcCtD
Anagrelide—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00507	0.0051	CcSEcCtD
Anagrelide—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00506	0.00509	CcSEcCtD
Anagrelide—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00502	0.00505	CcSEcCtD
Anagrelide—Ill-defined disorder—Telbivudine—hepatitis B	0.00495	0.00498	CcSEcCtD
Anagrelide—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00493	0.00495	CcSEcCtD
Anagrelide—Migraine—Lamivudine—hepatitis B	0.00491	0.00494	CcSEcCtD
Anagrelide—Malaise—Telbivudine—hepatitis B	0.00481	0.00484	CcSEcCtD
Anagrelide—Insomnia—Entecavir—hepatitis B	0.00479	0.00482	CcSEcCtD
Anagrelide—Somnolence—Entecavir—hepatitis B	0.00471	0.00474	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00471	0.00474	CcSEcCtD
Anagrelide—Dyspepsia—Entecavir—hepatitis B	0.00467	0.00469	CcSEcCtD
Anagrelide—Cough—Telbivudine—hepatitis B	0.00466	0.00468	CcSEcCtD
Anagrelide—Dehydration—Lamivudine—hepatitis B	0.00464	0.00467	CcSEcCtD
Anagrelide—Liver function test abnormal—Lamivudine—hepatitis B	0.00461	0.00463	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Entecavir—hepatitis B	0.00458	0.0046	CcSEcCtD
Anagrelide—Fatigue—Entecavir—hepatitis B	0.00457	0.00459	CcSEcCtD
Anagrelide—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00455	0.00458	CcSEcCtD
Anagrelide—Arthralgia—Telbivudine—hepatitis B	0.00454	0.00457	CcSEcCtD
Anagrelide—Chest pain—Telbivudine—hepatitis B	0.00454	0.00457	CcSEcCtD
Anagrelide—Myalgia—Telbivudine—hepatitis B	0.00454	0.00457	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00451	0.00453	CcSEcCtD
Anagrelide—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.0045	0.00452	CcSEcCtD
Anagrelide—Discomfort—Telbivudine—hepatitis B	0.00449	0.00451	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00447	0.00449	CcSEcCtD
Anagrelide—Gastrointestinal pain—Entecavir—hepatitis B	0.00433	0.00436	CcSEcCtD
Anagrelide—Influenza—Lamivudine—hepatitis B	0.00432	0.00434	CcSEcCtD
Anagrelide—Dysphagia—Lamivudine—hepatitis B	0.00432	0.00434	CcSEcCtD
Anagrelide—Nervous system disorder—Telbivudine—hepatitis B	0.00427	0.00429	CcSEcCtD
Anagrelide—Thrombocytopenia—Telbivudine—hepatitis B	0.00426	0.00429	CcSEcCtD
Anagrelide—Pancreatitis—Lamivudine—hepatitis B	0.00423	0.00425	CcSEcCtD
Anagrelide—Skin disorder—Telbivudine—hepatitis B	0.00423	0.00425	CcSEcCtD
Anagrelide—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00423	0.00425	CcSEcCtD
Anagrelide—Body temperature increased—Entecavir—hepatitis B	0.00419	0.00421	CcSEcCtD
Anagrelide—Abdominal pain—Entecavir—hepatitis B	0.00419	0.00421	CcSEcCtD
Anagrelide—Bronchitis—Lamivudine—hepatitis B	0.00415	0.00417	CcSEcCtD
Anagrelide—Abdominal discomfort—Lamivudine—hepatitis B	0.00414	0.00416	CcSEcCtD
Anagrelide—Pancytopenia—Lamivudine—hepatitis B	0.0041	0.00412	CcSEcCtD
Anagrelide—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00409	0.00411	CcSEcCtD
Anagrelide—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00409	0.00411	CcSEcCtD
Anagrelide—Dysuria—Lamivudine—hepatitis B	0.00404	0.00406	CcSEcCtD
Anagrelide—Pollakiuria—Lamivudine—hepatitis B	0.00399	0.00401	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00397	0.00399	CcSEcCtD
Anagrelide—Insomnia—Telbivudine—hepatitis B	0.00394	0.00396	CcSEcCtD
Anagrelide—Paraesthesia—Telbivudine—hepatitis B	0.00391	0.00393	CcSEcCtD
Anagrelide—Depression—Lamivudine—hepatitis B	0.00384	0.00386	CcSEcCtD
Anagrelide—Dyspepsia—Telbivudine—hepatitis B	0.00383	0.00385	CcSEcCtD
Anagrelide—Asthenia—Entecavir—hepatitis B	0.0038	0.00382	CcSEcCtD
Anagrelide—Renal failure—Lamivudine—hepatitis B	0.00378	0.0038	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00376	0.00378	CcSEcCtD
Anagrelide—Fatigue—Telbivudine—hepatitis B	0.00375	0.00377	CcSEcCtD
Anagrelide—Pain—Telbivudine—hepatitis B	0.00372	0.00374	CcSEcCtD
Anagrelide—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00371	0.00373	CcSEcCtD
Anagrelide—Sweating—Lamivudine—hepatitis B	0.00369	0.00371	CcSEcCtD
Anagrelide—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00366	0.00368	CcSEcCtD
Anagrelide—Hepatobiliary disease—Lamivudine—hepatitis B	0.00364	0.00366	CcSEcCtD
Anagrelide—Epistaxis—Lamivudine—hepatitis B	0.00363	0.00365	CcSEcCtD
Anagrelide—Diarrhoea—Entecavir—hepatitis B	0.00363	0.00365	CcSEcCtD
Anagrelide—Sinusitis—Lamivudine—hepatitis B	0.00361	0.00363	CcSEcCtD
Anagrelide—Feeling abnormal—Telbivudine—hepatitis B	0.00359	0.00361	CcSEcCtD
Anagrelide—Gastrointestinal pain—Telbivudine—hepatitis B	0.00356	0.00358	CcSEcCtD
Anagrelide—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00354	0.00356	CcSEcCtD
Anagrelide—Dizziness—Entecavir—hepatitis B	0.00351	0.00352	CcSEcCtD
Anagrelide—Rhinitis—Lamivudine—hepatitis B	0.00346	0.00348	CcSEcCtD
Anagrelide—Hepatitis—Lamivudine—hepatitis B	0.00345	0.00347	CcSEcCtD
Anagrelide—Abdominal pain—Telbivudine—hepatitis B	0.00344	0.00346	CcSEcCtD
Anagrelide—Body temperature increased—Telbivudine—hepatitis B	0.00344	0.00346	CcSEcCtD
Anagrelide—Hypoaesthesia—Lamivudine—hepatitis B	0.00344	0.00345	CcSEcCtD
Anagrelide—Pharyngitis—Lamivudine—hepatitis B	0.00343	0.00345	CcSEcCtD
Anagrelide—Connective tissue disorder—Lamivudine—hepatitis B	0.00339	0.00341	CcSEcCtD
Anagrelide—Vomiting—Entecavir—hepatitis B	0.00337	0.00339	CcSEcCtD
Anagrelide—Rash—Entecavir—hepatitis B	0.00334	0.00336	CcSEcCtD
Anagrelide—Dermatitis—Entecavir—hepatitis B	0.00334	0.00336	CcSEcCtD
Anagrelide—Headache—Entecavir—hepatitis B	0.00332	0.00334	CcSEcCtD
Anagrelide—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00329	0.00331	CcSEcCtD
Anagrelide—Rash—Adefovir Dipivoxil—hepatitis B	0.00326	0.00328	CcSEcCtD
Anagrelide—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00326	0.00327	CcSEcCtD
Anagrelide—Headache—Adefovir Dipivoxil—hepatitis B	0.00324	0.00326	CcSEcCtD
Anagrelide—Nausea—Entecavir—hepatitis B	0.00315	0.00316	CcSEcCtD
Anagrelide—Asthenia—Telbivudine—hepatitis B	0.00312	0.00314	CcSEcCtD
Anagrelide—Mediastinal disorder—Lamivudine—hepatitis B	0.00311	0.00313	CcSEcCtD
Anagrelide—Chills—Lamivudine—hepatitis B	0.0031	0.00312	CcSEcCtD
Anagrelide—Pruritus—Telbivudine—hepatitis B	0.00308	0.0031	CcSEcCtD
Anagrelide—Nausea—Adefovir Dipivoxil—hepatitis B	0.00307	0.00309	CcSEcCtD
Anagrelide—Alopecia—Lamivudine—hepatitis B	0.00305	0.00307	CcSEcCtD
Anagrelide—Malnutrition—Lamivudine—hepatitis B	0.00301	0.00302	CcSEcCtD
Anagrelide—Diarrhoea—Telbivudine—hepatitis B	0.00298	0.00299	CcSEcCtD
Anagrelide—Flatulence—Lamivudine—hepatitis B	0.00296	0.00298	CcSEcCtD
Anagrelide—Tension—Lamivudine—hepatitis B	0.00295	0.00297	CcSEcCtD
Anagrelide—Nervousness—Lamivudine—hepatitis B	0.00292	0.00294	CcSEcCtD
Anagrelide—Back pain—Lamivudine—hepatitis B	0.00291	0.00292	CcSEcCtD
Anagrelide—Muscle spasms—Lamivudine—hepatitis B	0.00289	0.00291	CcSEcCtD
Anagrelide—Dizziness—Telbivudine—hepatitis B	0.00288	0.00289	CcSEcCtD
Anagrelide—Ill-defined disorder—Lamivudine—hepatitis B	0.00279	0.0028	CcSEcCtD
Anagrelide—Anaemia—Lamivudine—hepatitis B	0.00278	0.00279	CcSEcCtD
Anagrelide—Vomiting—Telbivudine—hepatitis B	0.00277	0.00278	CcSEcCtD
Anagrelide—Rash—Telbivudine—hepatitis B	0.00275	0.00276	CcSEcCtD
Anagrelide—Dermatitis—Telbivudine—hepatitis B	0.00274	0.00276	CcSEcCtD
Anagrelide—Headache—Telbivudine—hepatitis B	0.00273	0.00274	CcSEcCtD
Anagrelide—Malaise—Lamivudine—hepatitis B	0.00271	0.00273	CcSEcCtD
Anagrelide—Syncope—Lamivudine—hepatitis B	0.0027	0.00271	CcSEcCtD
Anagrelide—Loss of consciousness—Lamivudine—hepatitis B	0.00264	0.00266	CcSEcCtD
Anagrelide—Cough—Lamivudine—hepatitis B	0.00262	0.00264	CcSEcCtD
Anagrelide—Convulsion—Lamivudine—hepatitis B	0.00261	0.00262	CcSEcCtD
Anagrelide—Nausea—Telbivudine—hepatitis B	0.00259	0.0026	CcSEcCtD
Anagrelide—Chest pain—Lamivudine—hepatitis B	0.00256	0.00257	CcSEcCtD
Anagrelide—Myalgia—Lamivudine—hepatitis B	0.00256	0.00257	CcSEcCtD
Anagrelide—Arthralgia—Lamivudine—hepatitis B	0.00256	0.00257	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00254	0.00256	CcSEcCtD
Anagrelide—Discomfort—Lamivudine—hepatitis B	0.00253	0.00254	CcSEcCtD
Anagrelide—Dry mouth—Lamivudine—hepatitis B	0.0025	0.00252	CcSEcCtD
Anagrelide—Confusional state—Lamivudine—hepatitis B	0.00247	0.00249	CcSEcCtD
Anagrelide—Oedema—Lamivudine—hepatitis B	0.00245	0.00247	CcSEcCtD
Anagrelide—Infection—Lamivudine—hepatitis B	0.00244	0.00245	CcSEcCtD
Anagrelide—Shock—Lamivudine—hepatitis B	0.00241	0.00243	CcSEcCtD
Anagrelide—Nervous system disorder—Lamivudine—hepatitis B	0.00241	0.00242	CcSEcCtD
Anagrelide—Thrombocytopenia—Lamivudine—hepatitis B	0.0024	0.00241	CcSEcCtD
Anagrelide—Skin disorder—Lamivudine—hepatitis B	0.00238	0.0024	CcSEcCtD
Anagrelide—Hyperhidrosis—Lamivudine—hepatitis B	0.00237	0.00238	CcSEcCtD
Anagrelide—Anorexia—Lamivudine—hepatitis B	0.00234	0.00235	CcSEcCtD
Anagrelide—Hypotension—Lamivudine—hepatitis B	0.00229	0.0023	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00224	0.00225	CcSEcCtD
Anagrelide—Insomnia—Lamivudine—hepatitis B	0.00222	0.00223	CcSEcCtD
Anagrelide—Paraesthesia—Lamivudine—hepatitis B	0.0022	0.00221	CcSEcCtD
Anagrelide—Dyspnoea—Lamivudine—hepatitis B	0.00219	0.0022	CcSEcCtD
Anagrelide—Somnolence—Lamivudine—hepatitis B	0.00218	0.00219	CcSEcCtD
Anagrelide—Dyspepsia—Lamivudine—hepatitis B	0.00216	0.00217	CcSEcCtD
Anagrelide—Decreased appetite—Lamivudine—hepatitis B	0.00213	0.00214	CcSEcCtD
Anagrelide—PDE3A—blood plasma—hepatitis B	0.00212	0.419	CbGeAlD
Anagrelide—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00212	0.00213	CcSEcCtD
Anagrelide—Fatigue—Lamivudine—hepatitis B	0.00212	0.00213	CcSEcCtD
Anagrelide—Constipation—Lamivudine—hepatitis B	0.0021	0.00211	CcSEcCtD
Anagrelide—Pain—Lamivudine—hepatitis B	0.0021	0.00211	CcSEcCtD
Anagrelide—Feeling abnormal—Lamivudine—hepatitis B	0.00202	0.00203	CcSEcCtD
Anagrelide—Gastrointestinal pain—Lamivudine—hepatitis B	0.00201	0.00202	CcSEcCtD
Anagrelide—Urticaria—Lamivudine—hepatitis B	0.00195	0.00196	CcSEcCtD
Anagrelide—Body temperature increased—Lamivudine—hepatitis B	0.00194	0.00195	CcSEcCtD
Anagrelide—Abdominal pain—Lamivudine—hepatitis B	0.00194	0.00195	CcSEcCtD
Anagrelide—Asthenia—Lamivudine—hepatitis B	0.00176	0.00177	CcSEcCtD
Anagrelide—Pruritus—Lamivudine—hepatitis B	0.00174	0.00175	CcSEcCtD
Anagrelide—Diarrhoea—Lamivudine—hepatitis B	0.00168	0.00169	CcSEcCtD
Anagrelide—Dizziness—Lamivudine—hepatitis B	0.00162	0.00163	CcSEcCtD
Anagrelide—Vomiting—Lamivudine—hepatitis B	0.00156	0.00157	CcSEcCtD
Anagrelide—Rash—Lamivudine—hepatitis B	0.00155	0.00156	CcSEcCtD
Anagrelide—Dermatitis—Lamivudine—hepatitis B	0.00155	0.00155	CcSEcCtD
Anagrelide—Headache—Lamivudine—hepatitis B	0.00154	0.00155	CcSEcCtD
Anagrelide—Nausea—Lamivudine—hepatitis B	0.00146	0.00147	CcSEcCtD
Anagrelide—CYP1A2—blood plasma—hepatitis B	0.000938	0.186	CbGeAlD
Anagrelide—PDE3A—blood—hepatitis B	0.000777	0.154	CbGeAlD
Anagrelide—PDE3A—liver—hepatitis B	0.000607	0.12	CbGeAlD
Anagrelide—CYP1A2—blood—hepatitis B	0.000344	0.068	CbGeAlD
Anagrelide—CYP1A2—liver—hepatitis B	0.000269	0.0532	CbGeAlD
